Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 24, 2021, Vaxcyte, Inc. (the "Company") was made aware of allegations
of sexual harassment and inappropriate conduct towards an employee of
GlaxoSmithKline plc ("GSK") by Moncef Slaoui, Ph.D., the Chairman of the
Company's Board of Directors (the "Board"), which occurred when he was an
employee of GSK.
Based on these allegations and in alignment with Vaxcyte's corporate values and
policies, the Board has requested Dr. Slaoui's resignation. Dr. Slaoui has
agreed and has resigned from the Board effective immediately.
Dr. Slaoui joined the Board in July 2017 and became Chairman of the Board in May
2018. Dr. Slaoui also served on the Compensation Committee. Dr. Slaoui's
resignation was not the result of any dispute or disagreement with the Company
or the Company's Board on any matter relating to the operations, policies or
practices of the Company.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses